Dr Lauren Koch, PHD | |
13126 W Sunset Hwy, Airway Heights, WA 99001 | |
(509) 957-8290 | |
Not Available |
Full Name | Dr Lauren Koch |
---|---|
Gender | Female |
Speciality | Psychologist |
Location | 13126 W Sunset Hwy, Airway Heights, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518368539 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lauren Koch, PHD 23237 E Settler Dr, Liberty Lake, WA 99019-8524 Ph: (509) 868-1881 | Dr Lauren Koch, PHD 13126 W Sunset Hwy, Airway Heights, WA 99001 Ph: (509) 957-8290 |
News Archive
A nationwide survey of hospitals has revealed a wide variety of approaches to newborn skincare – including the timing of the first bath – that could ultimately have lasting effects on a baby's health and wellbeing.
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
Antimalarial drugs appear to follow a typical pattern, with early effectiveness eventually limited by the emergence of drug resistance.
External beam radiation treatment has long been manipulated into the unique shape of patients' tumors for personalized cancer care. Technology providing a means of patient-specific radionuclide drug therapies has not been standardized, as it has been limited to software that requires oncologists to manually define the areas of tumors.
ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.
› Verified 6 days ago